Page last updated: 2024-08-22

zalcitabine and Leukemia, Myeloid, Acute

zalcitabine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Avizonis, D; Bader, GD; Bridon, G; Gronda, M; Hurren, R; Laposa, R; Liyanage, SU; MacLean, N; Minden, MD; Schimmer, AD; Shamas-Din, A; Siriwardena, TP; Sriskanthadevan, S; Voisin, V; Wang, X; Xu, C; Yehudai, D	1

Other Studies

1 other study(ies) available for zalcitabine and Leukemia, Myeloid, Acute

Article	Year
Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML. Blood, 2017, 05-11, Volume: 129, Issue:19 Topics: Animals; Cell Line, Tumor; Cells, Cultured; DNA Replication; DNA, Mitochondrial; Humans; Leukemia, Myeloid, Acute; Mice, SCID; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Phosphate Kinase; Oxidative Phosphorylation; Phosphotransferases; Signal Transduction; Tumor Cells, Cultured; Zalcitabine	2017

Article

Year

Leveraging increased cytoplasmic nucleoside kinase activity to target mtDNA and oxidative phosphorylation in AML.

Blood, 2017, 05-11, Volume: 129, Issue:19

Topics: Animals; Cell Line, Tumor; Cells, Cultured; DNA Replication; DNA, Mitochondrial; Humans; Leukemia, Myeloid, Acute; Mice, SCID; NM23 Nucleoside Diphosphate Kinases; Nucleoside-Phosphate Kinase; Oxidative Phosphorylation; Phosphotransferases; Signal Transduction; Tumor Cells, Cultured; Zalcitabine

2017